Filtered By:
Specialty: Surgery
Cancer: Hepatoblastoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens
ConclusionThe cytotoxic effects of CDDP and THP were both enhanced under HO-1 knockdown conditions as well as under conditions that inhibit the activation pathway of HO-1 by EGFR inhibitors. EGFR/HO-1 axis may be involved in acquiring chemoresistance in HepG2 cell lines as well as in human hepatoblastoma.
Source: Pediatric Surgery International - September 25, 2019 Category: Surgery Source Type: research
